WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · HB 1346

Legislative bill overview

HB 1346 establishes regulatory framework for low-THC hemp extract products in Indiana. The bill defines parameters for what qualifies as "low THC" hemp extract, likely setting maximum THC concentration thresholds and specifying allowable uses, production standards, or distribution channels for these products.

Why is this important

Hemp-derived products represent a growing market segment, and states differ significantly in how they regulate these substances. Clear state-level definition and regulation could provide consumer protection, establish legal clarity for businesses, and generate potential tax revenue—while also clarifying Indiana's position relative to federal hemp regulations under the Farm Bill.

Potential points of contention

  • THC threshold definition: Disagreement over what "low THC" means numerically (0.3%, 1%, 5%?) affects market access and federal compliance
  • Product scope: Whether the law covers only extracts or also includes edibles, inhalables, and other derivative products; what uses are permitted
  • Regulatory burden: Small producers may face compliance costs if licensing, testing, and reporting requirements are extensive, potentially favoring larger companies
  • Federal-state conflict: Potential tension between state approval and federal scheduling of cannabinoids, creating legal uncertainty for businesses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.